VARICELLA ZOSTER VIRUS-VIRUS LIKE PARTICLES (VLPS) AND ANTIGENS
    6.
    发明公开
    VARICELLA ZOSTER VIRUS-VIRUS LIKE PARTICLES (VLPS) AND ANTIGENS 审中-公开
    VARICELLA ZOSTER VIRUS-VIRUSÄHNLICHEPARTIKEL(VLP)UND ANTIGENE

    公开(公告)号:EP2175882A4

    公开(公告)日:2011-11-30

    申请号:EP08796366

    申请日:2008-07-21

    申请人: NOVAVAX INC

    IPC分类号: A61K39/25 A61K39/245

    摘要: The present invention discloses novel Varicella Zoster Virus (VZV) virus-like particles (VLPs) comprising glycoprotein E of VZV. The invention also discloses vaccine formulations of the VZV-VLPs and methods of inducing an immune response in subjects.

    摘要翻译: 本发明公开了包含VZV糖蛋白E的新型水痘带状疱疹病毒(VZV)病毒样颗粒(VLP)。 本发明还公开了VZV-VLP的疫苗制剂和在受试者中诱导免疫应答的方法。

    RESPIRATORY SYNCYTIAL VIRUS-VIRUS LIKE PARTICLE (VLPS)
    7.
    发明公开
    RESPIRATORY SYNCYTIAL VIRUS-VIRUS LIKE PARTICLE (VLPS) 审中-公开
    维生素D分泌酶抑制剂SYNZYTIALVIRUS

    公开(公告)号:EP2089515A4

    公开(公告)日:2011-02-23

    申请号:EP07864554

    申请日:2007-11-16

    申请人: NOVAVAX INC

    IPC分类号: C12N7/00

    摘要: The present invention discloses and claims virus like particles (VLPs) that express and/or contains RSV proteins. The invention includes vector constructs comprising said proteins, cells comprising said constructs, formulations and vaccines comprising VLPs of the inventions. The invention also includes methods of making and administrating VLPs to vertebrates, including methods of inducing immunity to infections, including RSV.

    摘要翻译: 本发明公开并要求表达和/或含有RSV蛋白的病毒样颗粒(VLPs)。 本发明包括包含所述蛋白质的载体构建体,包含所述构建体的细胞,制剂和包含本发明的VLP的疫苗。 本发明还包括制备和施用VLP到脊椎动物的方法,包括诱导感染免疫的方法,包括RSV。

    RECOMBINANT E-SELECTIN MADE IN INSECT CELLS
    9.
    发明公开
    RECOMBINANT E-SELECTIN MADE IN INSECT CELLS 审中-公开
    在INSEKTENZELLEN PRODUZIERTES REKOMBINANTES E-SELECTIN

    公开(公告)号:EP1871802A4

    公开(公告)日:2008-12-24

    申请号:EP06737507

    申请日:2006-03-08

    申请人: NOVAVAX INC

    IPC分类号: C07K14/78 A61K38/39

    CPC分类号: C07K14/70564 A61K38/00

    摘要: The inventive features include recombinant mammalian E-selectin peptides, nucleic acids encoding said peptides, vectors and cells having these nucleic acids, and methods of making the peptides. Further inventive features include methods of treating diseases and conditions associated with inflammation using recombinant mammalian E-selectin peptides to induce mucosal tolerance to E-selectin.

    摘要翻译: 本发明的特征包括重组哺乳动物E-选择素肽,编码所述肽的核酸,载体和具有这些核酸的细胞,以及制备所述肽的方法。 进一步的发明特征包括使用重组哺乳动物E-选择素肽治疗与炎症相关的疾病和病症以诱导对E-选择蛋白的粘膜耐受性的方法。